For the Quarter Ending September 2025
North America
• In the United States, the Doxylamine Succinate Price Index rose quarter-over-quarter in Q3 2025, driven by increasing production costs.
• Producer Price Index increased 2.6% year-over-year in August 2025, reflecting rising input costs for Doxylamine Succinate production.
• Consumer Price Index rose 3.0% year-over-year in September 2025, indicating higher operational costs for manufacturers.
• Doxylamine Succinate demand was supported by robust 5.42% year-over-year retail sales growth in September 2025.
• A low unemployment rate of 4.3% in September 2025 bolstered consumer confidence, supporting demand for OTC products.
• Raw material inventories for chemical manufacturers continued to shrink in Q3 2025, impacting supply dynamics.
• Organic chemical input costs experienced upward pressure in Q3 2025, contributing to higher Doxylamine Succinate expenses.
• US chemical manufacturing activity appeared to contract in Q3 2025, affecting overall supply chain efficiency.
• Natural gas prices experienced year-over-year spiking in Q3 2025, influencing energy feedstock costs.
Why did the price of Doxylamine Succinate change in September 2025 in North America?
• Input and raw materials costs for chemical manufacturers increased during Q3 2025.
• The Producer Price Index rose 2.6% year-over-year in August 2025, reflecting higher production expenses.
• Shrinking raw material inventories for chemical manufacturers in Q3 2025 contributed to supply pressures.
Europe
• In Germany, the Doxylamine Succinate Price Index rose quarter-over-quarter in Q3 2025, driven by persistent high energy and raw material costs.
• Doxylamine Succinate production costs faced upward pressure in Q3 2025, with ammonia prices rising and high energy costs challenging the industry.
• Demand for Doxylamine Succinate was supported by increased pharmaceutical production in Germany during Q3 2025.
• Germany's Manufacturing Index contracted in Q3 2025, reflecting a broader industrial slowdown and impacting overall chemical demand.
• The Consumer Price Index increased by 2.4% in September 2025, indicating rising operational costs and reduced consumer purchasing power.
• Retail sales in Germany rose by 0.2% in September 2025, suggesting stable consumer demand for Doxylamine Succinate in OTC products.
• Ammonia supply in Europe tightened in Q3 2025 due to facility maintenance and increased power-sector offtake.
• The Producer Price Index declined by 1.7% in September 2025, primarily due to lower energy prices, offering some cost relief.
Why did the price of Doxylamine Succinate change in September 2025 in Europe?
• Production costs increased due to rising ammonia prices and persistent high energy costs in Q3 2025.
• Demand was supported by increased pharmaceutical production, despite a contracting Manufacturing Index in Q3 2025.
• The Consumer Price Index rose 2.4% in September 2025, while the Producer Price Index declined 1.7%.
APAC
• In China, the Doxylamine Succinate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
• Doxylamine Succinate production costs decreased in Q3 2025, with the Producer Price Index falling -2.3% year-over-year.
• Organic chemical intermediate costs, including phenol and acetone, declined in Q3 2025 due to oversupply.
• Demand outlook was mixed; CPI fell -0.3% year-over-year, and consumer confidence was 89.6 in September 2025.
• Retail sales increased 3.0% year-over-year, with unemployment at 5.2% in September 2025, supporting some spending.
• Industrial production grew 6.5% year-over-year in September 2025, despite the Manufacturing Index contracting.
• Chemical manufacturers faced inventory accumulation in Q3 2025, constraining their ability to maintain higher offers.
• The Doxylamine Succinate price forecast suggests continued downward pressure from oversupply and reduced input costs.
Why did the price of DOXYLAMINE SUCCINATE change in September 2025 in APAC?
• Producer prices fell -2.3% year-over-year in September 2025, reducing Doxylamine Succinate costs.
• Inventory accumulation by manufacturers in Q3 2025 pressured Doxylamine Succinate pricing downwards.
• Weak consumer demand, with a -0.3% CPI year-over-year in September 2025, impacted sales.
